Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
17–18 March 2020, San Diego, CA, USA
3rd Annual Formulation & Drug Delivery USA Congress
Observe and discuss the latest improvements in the pharmaceutical development of small molecule and biologic drug products at Oxford Global’s Formulation & Drug Delivery USA Congress.
Drug delivery and formulation can make or break the commercial success of a product. With solubility and bioavailability remaining key challenges from conception to commercial success and with the increasing prevalence of biologics, now more than ever guidance and knowledge-sharing is needed in overcoming these issues.
Join those industry leaders shaping the field to discuss critical industry topics such as:
- Featured sessions on nano& RNA formulation and delivery, Opthalmic delivery and Gene Therapy
- Continuous manufacturing development
- Advances in small molecule Formulation and drug delivery
- New biologics Formulation innovation and drug delivery systems/strategies
Featuring over 55+ renowned industry speakers from leading organisations such as Merck, Takeda and AstraZeneca, this programme will allow you to discuss the key topics that interest you with over 250 senior level attendees.
View Agenda: https://bit.ly/36LdKGr
2020 will see the congress co-located with our Inhalation & Respiratory Drug Delivery Congress USA giving you wider access to a range of experts working in the field.
2020 Live Webinars:
“Understanding Supersaturation Of Small Molecule To Improve Oral Bioavailability” hosted by Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research
“Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development” hosted by Hovik Gukasyan, Associate Director, Early Development Formulation and Physical Chemistry, Allergan
Go Social: For the latest conference updates follow us on Twitter @FDDCongress and join the congress conversation on #FDDUS20
For more information about the event, please contact Emily Hawkings at [email protected]